1
0
0
News
IAG VO Aktuell geplante und rekrutierende multizentrische, ...Deutsche Krebsgesellschaft
www.krebsgesellschaft.de
Dominik Modest. Medizinische Klinik mit Schwer- punkt Hämatologie, Onkologie ... E: . Studiennummer: IAG-VO Kurztitel: ANTONIO.
Prof. Dr. med. Dominik Modest erhielt Curt Meyer ...krebs-nachrichten.de
www.krebs-nachrichten.de
— Der Preisträger Prof. Dr. Dominik Modest hat an der FU Berlin Humanmedizin studiert. An der Charité promovierte er im Jahr mit einer Arbeit ...
2021 Referenten - BerlinAIO Herbstkongress
www.aio-herbstkongress.de
Dominik Modest. Charité – Universitätsmedizin Berlin Medizinische Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie. PngItem_ Dr. Friedrich ...
How can we understand and define re-challenge?COR2ED
cor2ed.com
Dr Dominik Modest addresses the clinical question: how can we understand and define re-challenge in the treatment of mCRC?
Netzwerk-Profile
LinkedIn: Dominik Modest – Oberarzt – Charité | LinkedInde.linkedin.com › dominik-modest-1a
Sehen Sie sich das Profil von Dominik Modest im größten Business-Netzwerk der Welt an. Im Profil von Dominik Modest ist 1 Job angegeben.
Twitter Profil: Dominik Paul Modest (@ModestDominik) X · ModestDominik140+ Follower
Podcast episode 1: lower GI cancer Dr Jenny Seligmann and Dr Dominik Modest discuss key abstracts on lower GI cancer from ESMO in Episode 1 of this. 4.
Interessen
Role of Radiotherapy in Rectal Cancer - Decision PointMedscape
decisionpoint.medscape.com
— Dominik Modest, MD, discusses the role of radiotherapy in rectal cancer.
Business-Profile
Dominik Paul Modest Charité Universitätsmedizin BerlinResearchGate
www.researchgate.net
Dominik Paul Modest. Charité Universitätsmedizin Berlin | Charité · Medical Department, Division of Hematology, Oncology and Tumor Immunology · About · Network.
Bücher
Serum levels of soluble programmed death protein 1 (sPD- ...Taylor & Francis Online
www.tandfonline.com
von S Kruger · · Zitiert von: 133 — Dominik Modest has received Honoraria and research funding from. Roche. Volker Heinemann has received honoraria for scientific presentations.
Dokumente zum Namen
ASCO-GI 2024: ADJUBIL - Cancer Trial ResultsLARVOL
clin.larvol.com
... Dominik Modest. Affiliations. Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center and Frankfurter Institut für ...
Abstract 5170: Linking tumor evolution and therapy response ...aacrjournals.org
aacrjournals.org
von S Mamlouk · — Dominik Modest;. Dominik Modest. 4Ludwig Maximilians University ... Dominik Modest, Kerstin Möhr, Markus Morkel, Reinhold Schäfer, Christine Sers.
FIRE-9 - PORTClinicalTrials.gov
classic.clinicaltrials.gov
von SCU Berlin — Dominik Modest. FIRE-9 PORT. 28-Sep EudraCT no Dominik Modest. Charité – Universitätsmedizin Berlin. Medizinische Klinik ...
Prospective, randomized, open, multicenter Phase II trial totumor-online.de
www.tumor-online.de
— Dominik Modest, Charité - Universitätsmedizin Berlin; shipment during screening and after start of study treatment permitted. 20 About 20 mL ...
Wissenschaftliche Veröffentlichungen
Professor Dr. Dominik Modest - DFG - GEPRISDeutsche Forschungsgemeinschaft
gepris.dfg.de
Professor Dr. Dominik Modest, Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie (CVK)Berlin.
Peer Review reports - BMC Cancer - BioMed CentralBMC Cancer
bmccancer.biomedcentral.com
Reviewer Report - Dominik Modest. 22 Feb 2017, Author responded, Author comments - Dan Liu. Resubmission - Version Feb 2017, Submitted, Manuscript version ...
Curt Meyer-Gedächtnispreis geht an Prof. Dr. ...Charité – Universitätsmedizin Berlin
www.charite.de
— Die Berliner Krebsgesellschaft hat den Onkologen Prof. Dr. Dominik Modest von der Charité – Universitätsmedizin Berlin mit dem diesjährigen ...
Advances in the management of mCRCAmgen
science.amgen.ch
— Dominik Modest, Germany. Oncolytic immunotherapy: a new treatment option for patients with liver metastases? Markus Möhler, Germany. Closing ...
Veröffentlichungen allgemein
Curt Meyer-Gedächtnispreis geht an Prof. Dr. med. ...Springer
link.springer.com
von D Modest–ein — Dominik Modest von der Charité hat in diesem Jahr den mit € dotierten Curt ... Dominik Modest – ein. Experte für den metastasierten. Darmkrebs. Seit
GOBLEToncolyticsbiotech.com
oncolyticsbiotech.com
Dirk Arnold 1, Dominik Modest 2, Eray Goekkurt 3, Alexander Stein 3, Anke Reinacher-Schick 4, Nina Burkhart 1, Matt Coffey 5 , Ruimei Li 6, Thomas Heineman 6.
Video & Audio
ASCO-GI 2019: Dominik Modest: Colon Cancer - VimeoVimeo
vimeo.com
PD Dr. med. Dominik Modest, München Colon Cancer - Personal Highlights Recorded at The Gastrointestinal Cancers Symposium San Francisco, ...
Post-Kongress: ASCO-GI OnkoLiveSTREAMED UP
streamed-up.com
Prof. Dr. med. Jörg Trojan. 00:33:44. Kolorektales Karzinom. Prof. Dr. med. Dominik Modest. 00:58:58. Sponsoren. Medienpartner. Fachgebiete. Onkologie ...
Cancers of the upper GI tract by Dr. Dominik Modest - VimeoVimeo
vimeo.com
... Dominik Modest. Follow. from COR2ED. 7 years ago. Recommended; Description; Comments. Cancer of the Liver, Small Intestine and Pancreas tract by Prof.
Supporting oncology professionals through educationecancer
ecancer.org
Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany. VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer ( Dr ...
Sonstiges
Prof. Doutor Dominik Modest aborda o desenvolvimento do ...My Oncologia
www.myoncologia.pt
— O Prof. Doutor Dominik Modest começou por salientar que a seleção de doentes com cancro colorretal metastático, através da utilização de ...
Dominik Paul Modest - Senior Physician, Berlin, GermanyeMedEvents
www.emedevents.com
Dominik Modest MD. Oncology, Internal Medicine. Connect with the speaker? Contact Us. Dr. Dominik Paul Modest, MD is a Senior Physician at ...
Curt Meyer-Gedächtnispreis geht an Prof. Dr. med. ...Berliner Krebsgesellschaft
www.berliner-krebsgesellschaft.de
Dominik Modest von der Charité Berliner Krebsgesellschaft zeichnet den Onkologen für seine klinische Forschung zum Darmkrebs im metastasierten ...
ADJUBIL: phase II study of adjuvant immunotherapy with ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von T Goetze — ... Dominik Modest. Affiliations. 1 Krankenhaus Nordwest, University Cancer Center Frankfurt, Steinbacher Hohl 2-26, Frankfurt, Germany
ASO Visual Abstract: Sodium Thiosulfate Reduces Acute ...ProQuest
search.proquest.com
von K Annika · — ... Dominik Modest, MD1, Beate Rau, MD2, and Linda Feldbrügge, MD2 1Department of Hematology, Oncology and Tumorimmunology, Corporate Member of Freie ...
Acknowledgement to Reviewers 2019Cancer Treatment Reviews
www.cancertreatmentreviews.com
Dominik Modest, Germany. Nicola Normanno, Italy. Ana Oaknin, Spain. Eileen M. O'Reilly, United States. Demetris Papamichael, Cyprus. J. Alejandro Perez-Fidalgo ...
ESMO Asia Congress 2024: Scientific CommitteeEuropean Society for Medical Oncology
www.esmo.org
Dominik Modest, Berlin, Germany; Do-Youn Oh, Seoul, Korea; Tim Price, Woodville, Australia; Raghav Sundar, Singapore; Julien Taieb, Paris, France; Fen Wang ...
Future directions neoadjuvant versus adjuvant - OncologyPROEuropean Society for Medical Oncology
oncologypro.esmo.org
... Cancer. Presenters. Dominik Modest. Authors. D.P. Modest. Author affiliations. Medicine Department Of Hematology, Oncology And Tumorimmunology, Charité ...
GI CONNECT Update from ESMO Ep 1: lower GI cancer ...Castos
cor2ed-medical-education.castos.com
— ... Dominik Modest, Medical Oncologist from the Charité Universitaetsmedizin, Berlin, Germany discuss a number of key oral presentations from ...
German AIO Study Krk (FIRE-3)Annals of Oncology
www.annalsofoncology.org
von D Modest · · Zitiert von: 12 — Dominik Modest. Dominik Modest. Affiliations. Department of Medical Oncology & Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany.
Impact of the Specific Mutation in KRAS Codon Karger Publishers
karger.com
von DP Modest · · Zitiert von: 32 — Dominik Modest. Department of Medical Oncology. Klinikum Grosshadern, University ... Tel: + , E-Mail dominik.modest @ med.uni-muenchen.
PROTECTOR - AIO Arbeitsgemeinschaft ...Arbeitsgemeinschaft Internistische Onkologie in der Deutschen Krebsgesellschaft eV
www.aio-portal.de
Leitung. Prof. Dr. med. Dominik Modest. Ansprechpartner*in. Dr. rer.nat. Inna Hoyer Telefon + Zurück.
Post-resection therapy in patients with metastatic colorectal ...Dimensions AI
app.dimensions.ai
Investigators · Dominik Modest - Charité - University Medicine Berlin. PI · Volker Heinemann - LMU Klinikum. Co-PI · Johann Pratschke - Charité - University ...
Post-resection/Ablation Chemotherapy in Patients With ...ClinicalTrials.gov
classic.clinicaltrials.gov
Contact: Dominik Modest, Prof. Dr. + ext , . Contact: Daniel Müller, Dr. + ext 125, mueller.daniel@ikf-khnw ...
Research in progressOnkowissen TV
www.onkowissen.tv
Hyperselektion mit ctDNA zukunftsweisend für Therapie… Prof. Dr. med. Dominik Modest. ASCO GI Erste randomisierte Studie zur kombinierten… Prof. Dr. med ...
Reviewers 2018European Journal of Cancer
www.ejcancer.com
Dominik Modest. Filippo Montemurro. Daniel A. Morgenstern. Bruce Morland. Elisabetta Munzone. Jens Neumann. Bart Neyns. Matthias Ocker. Filippo Pietrantonio.
Stage 4 Colon CancerVuMedi
www.vumedi.com
FEATURING Dominik Modest. 77 views; August 4, :02 · Yale Cancer Center · Personalized Treatment for Patients Living With mCRC. FEATURING Michael ...
Post-resection/Ablation Chemotherapy in Patients With ...Journal Onkologie
www.journalonko.de
— Dominik Modest, Prof. Dr. Principal Investigator Charite University, Berlin, Germany. Kontakt. Dominik Modest, Prof. Dr. Kontakt: Phone: +
Targeted Colorectal Cancer Combo Improves QoLMDedge
www.mdedge.com
— Dominik Modest, MD, presented these new results of the phase 3 CodeBreaK 300 trial at the ASCO Gastrointestinal Cancers Symposium. The ...
A Randomized, Controlled Study—XELAVIRI (AIO KRK0110)ASCO Publications
ascopubs.org
von DP Modest · · Zitiert von: 50 — Authors: Dominik Paul Modest, MD -muenchen.de, Ludwig Fischer von Weikersthal, MD, Thomas Decker, PhD, Ursula Vehling-Kaiser, MD, Jens ...
sortiert nach Relevanz / Datum